QCM Cayman’s Medtronic MDT Stock Holding History

QCM Cayman’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,254	Closed	-$644K	–	222
2015 Q1	$644K	Buy	+8,254	New	+$626K	0.34%	45

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

QCM Cayman's MDT Position: Q2 2015 in Review

QCM Cayman sold out of Medtronic (MDT) in Q2 2015, closing a stake of 8,254 shares — an estimated $644K sold.

QCM Cayman first reported a position in MDT in Q1 2015 and held it in 1 quarter. The position peaked at $644K in Q1 2015. 1,259 funds tracked by Wall St. Rank hold MDT as of Q2 2015.

QCM Cayman reported no remaining Medtronic position as of Q2 2015 after selling out during the quarter.
QCM Cayman sold 8,254 Medtronic shares in Q2 2015, an estimated $644K.
QCM Cayman first reported a position in Medtronic in Q1 2015 and held it in 1 quarter.
QCM Cayman's Medtronic position peaked at $644K in Q1 2015.
1,259 funds tracked by Wall St. Rank held Medtronic as of Q2 2015.

Based on QCM Cayman's 13F filing for Q2 2015, filed 14 Aug 2015.